Stock Taper
SCREENER COMPARE ANY 2 STOCKS
INSM
INSMED INCORPORATED
NASDAQ
$118.54
▼ DOWN 2.35% (-2.85)

KEY STATISTICS

Market Cap$25.69 B
52w High$212.75
52w Low$90.39
Dividend Yield—
Frequency—
P/E-28.84
Volume1.98M
Shares Out.216.75M

COMPANY

LEADERSHIP

William H. Lewis
CHIEF EXECUTIVE
William H. Lewis

COMPENSATION 2026

Salary$854,550
Stock Awards$2,999,940
Incentive Plan Pay$1,495,463
All Other Comp.$117,407
Total$14,467,393

ABOUT

SECTOR
Healthcare
WENT PUBLIC
June 1, 2000
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
1,664

PRICE TARGET

Target High$235.00
Target Low$169.00
Target Median$195.00
Target Consensus$196.85

UPCOMING EARNINGS

DateOct 29, 2026
DayThursday
Rev. Est.$501.22M
OCT
29
THU

SPLIT RECORD

DATETYPERATIO
2011-03-03Reverse1:10
2000-07-31Reverse1:4

PRICE

$118.54 ▼ DOWN 2.35% (−$2.85)
OVERLAYS
$118$119$1209:33 AM10:37 AM11:42 AM12:46 PM1:50 PM2:55 PM3:59 PM118.54

About Insmed Incorporated

https://www.insmed.com ↗

Insmed Incorporated is a biopharmaceutical company developing and commercializing therapies for serious and rare diseases, including ARIKAYCE for lung disease and investigational treatments for bronchiectasis and pulmonary hypertension.

INDUSTRY

Biotechnology

A PRODUCT INSMED INCORPORATED IS KNOWN FOR

BRINSUPRI™ (brensocatib)
BRINSUPRI™ (brensocatib)

BRINSUPRI™ (brensocatib), FDA-approved in August 2025, is the first oral DPP1 inhibitor treatment for non-cystic fibrosis bronchiectasis, targeting disease-related inflammation.

COMPETITORS

COMPETITOR
ARWR COMPARE
AZN COMPARE
REGN COMPARE
SNY COMPARE

Revenue by Products

IconPRODUCTQ1-2025Q2-2025Q4-2025
Reportable Segment$92.82M $107.42M ▲$406.19M ▲

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
UNITED STATES$102.03M $217.96M ▲$270.07M ▲$378.74M ▲
NonUS$40.31M $113.16M ▲$35.9M ▼$46.74M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
511
LISTED HERE
26
RANKED BY POSITION SIZE
VTS.AX
0.03% · 6.9M
IBB
1.83% · 1.6M
XBI
1.17% · 1.2M
CGGR
0.25% · 530.8K
SCHG
0.10% · 525.3K
JGRO
0.51% · 419.3K
HNDX.DE
0.67% · 178.7K
HMWA.L
0.07% · 103.1K
BBH
2.55% · 101.1K
FHLC
0.35% · 100.9K
XDWH.DE
0.30% · 99.3K
DFUS
0.04% · 72.0K
XZ
XZME.F
0.09% · 71.8K
TMSL
0.23% · 58.1K
JHMM
0.11% · 54.4K
PB
PBPH
0.56% · 47.7K
LABU
0.80% · 41.9K
WINN
0.42% · 41.7K
GSEW
0.24% · 40.9K
WRDUSW.SW
0.03% · 40.6K
PBUS
0.04% · 37.1K
BKLC
0.04% · 17.9K
RECS
0.03% · 17.4K
TPU.TO
0.04% · 15.3K
BBP
1.52% · 15.0K
PINK
0.45% · 14.3K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
71.97%
HOLDERS
922
TOP 12 OF 922 · RANKED BY POSITION SIZE
Jpmorgan Chase & Co
24.2M sh · $3.7B
Vanguard Group Inc
21.1M sh · $3.67B
Darwin Global Management, Ltd.
20.9M sh · $3.64B
Blackrock, Inc.
16.7M sh · $2.73B
Fmr LLC
16.1M sh · $1.72B
Blackrock Inc.
14.3M sh · $955.72M
Baker Bros. Advisors LP
8.8M sh · $937.84M
Capital International Investors
8.2M sh · $878.34M
Price T Rowe Associates Inc /Md/
6.9M sh · $998.2M
Artisan Partners Limited Partnership
6.5M sh · $1.07B
Ameriprise Financial Inc
6.2M sh · $658.88M
Orbis Allan Gray Ltd
6.1M sh · $647.88M

RATINGS SNAPSHOT

Overall rating: D+

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score1

TRADES BY CONGRESS

HOUSE TRADES
Josh Gottheimer
Josh Gottheimer
Sale
2026-06-10
 Gilbert Cisneros
Gilbert Cisneros
Sale (Full)
2025-10-03

INSIDER TRADES

★
DIRECTOR
SHAROKY MELVIN MD
Sale · 5.0K shares
2026-08-17
★
OFFICER: CHIEF OPERATING OFFICER
Adsett Roger
Purchase · 81.0K shares
2026-08-10
★
OFFICER: CHIEF OPERATING OFFICER
Adsett Roger
Sale · 239.8K shares
2026-08-10
★
OFFICER: CHIEF OPERATING OFFICER
Adsett Roger
Sale · 76.6K shares
2026-08-10

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 9
OVERWEIGHT 5
OUTPERFORM 4
18 GRADES IN THE LAST 12 MONTHS
Truist Securities BUY JP Morgan OVERWEIGHT Evercore ISI Group OUTPERFORM Wells Fargo OVERWEIGHT Guggenheim BUY RBC Capital OUTPERFORM Roth Capital BUY Barclays OVERWEIGHT

SECTORS PEERS

PEERPRICE
TAK$18.03COMPARE
CAH$234.55COMPARE
HUM$385.54COMPARE
HLN$10.11COMPARE
A$153.85COMPARE
IQV$261.75COMPARE
ONC$366.73COMPARE
ALC$72.01COMPARE